Oppenheimer Downgrades Lightning eMotors to Perform
Oppenheimer analyst Colin Rusch downgrades Lightning eMotors (NYSE:ZEV) from Outperform to Perform.
BMO Capital Downgrades Precision BioSciences to Market Perform, Lowers Price Target to $4
BMO Capital analyst Kostas Biliouris downgrades Precision BioSciences (NASDAQ:DTIL) from Outperform to Market Perform and lowers the price target from $7 to $4.
JMP Securities Downgrades Seagen to Market Perform
JMP Securities analyst Reni Benjamin downgrades Seagen (NASDAQ:SGEN) from Market Outperform to Market Perform.
JP Morgan Downgrades Crestwood Equity Partners to Neutral, Lowers Price Target to $28
JP Morgan analyst Jeremy Tonet downgrades Crestwood Equity Partners (NYSE:CEQP) from Overweight to Neutral and lowers the price target from $31 to $28.
Raymond James Downgrades Qualtrics International to Market Perform
Raymond James analyst Brian Peterson downgrades Qualtrics International (NASDAQ:XM) from Outperform to Market Perform.
Jefferies Downgrades Provention Bio to Hold, Announces $25 Price Target
Jefferies analyst Chris Howerton downgrades Provention Bio (NASDAQ:PRVB) from Buy to Hold and announces $25 price target.
Piper Sandler Downgrades Qualtrics International to Neutral, Announces $18.15 Price Target
Piper Sandler analyst Brent Bracelin downgrades Qualtrics International (NASDAQ:XM) from Overweight to Neutral and announces $18.15 price target.
Piper Sandler Downgrades Ncino to Neutral, Lowers Price Target to $22
Piper Sandler analyst Brent Bracelin downgrades Ncino (NASDAQ:NCNO) from Overweight to Neutral and lowers the price target from $30 to $22.
Tesla Shares Downgraded On ‘Macro Challenges’: How The Collapse Of SVB Financial Could Impact EV Leader
An analyst is downgrading shares of electric vehicle leader Tesla Inc (NASDAQ: TSLA), and the fallout from the collapse of several banks is one reason why.
Raymond James Downgrades First Republic Bank, Outlines Risks In ‘Uncertain Environment’
Raymond James analyst David Long released a note on First Republic Bank (NYSE: FRC), downgrading his rating from a Strong Buy to Market Perform, but did not change his price target of $150 a share.